CTRI/2013/03/003480Other未知
Compassionate use of Arsenic trioxide in patients with Aplastic Anemia.
Principal Investigator Research Fund0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- Other
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Acquired aplastic anaemia
- •2.Age above 18 years
- •3.Patient / Legally Acceptable Representative able to provide informed consent
- •4.Hypocellular bone marrow- < 25%
- •5.With any severity of disease as defined below:
- •A. Not Severe Aplastic Anaemia
- •i. Hb <10g/dL
- •ii. ANC <1,500 cells/mm3
- •iii. PL <100 Ã? 109/L
- •B. Severe Aplastic Anaemia
- •i. Neutrophil count 0.5 x 109/l
- •ii. Platelets < 20 x 109/l
- •iii. Reticulocytes < 20 x109/l
- •C. Very Severe Aplastic Anaemia
- •i.If the ANC is < 200 cells/mm3
- •6.Prior treatment with any of the standard treatment Equine/rabbit Antithymocyte Globulin (ATG) and or cyclosporine or other drugs danazol, mycophenolate, prednisolone etc.
排除标准
- •History of cancer, renal failure, HIV positive status, Clonal disorders, pregnancy, participation in another investigational study 30-days before the current study
研究者
相似试验
尚未招募
4 期
Clinical efficacy of arsenic trioxide combined with carboplatin for neoadjuvant chemotherapy for locally advanced cervical cancerCervical cancerITMCTR1900002399The First Affiliated Hospital of Guangzhou University of Chinese Medicine
招募中
2 期
Post remission therapy including arsenic trioxide against acute promylocytic leukemia over 65 years old, Phase II Clinical Study (JALSG APL212G study)Adult acute promylocytic leukemiaJPRN-UMIN000008471the Japan Adult Leukemia Study Group (JALSG)63
已完成
1 期
Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AMLMyelodysplastic SyndromeNCT00195104Weill Medical College of Cornell University87
Unknown
2 期
Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic LeukemiaAcute Promyelocytic LeukemiaNCT00517712Christian Medical College, Vellore, India400
已完成
1 期
Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic LeukemiaLeukemiaNCT00008697Washington University School of Medicine13